Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis

Background. Pancreatic enzyme replacement therapy is the standard of care for treatment of malabsorption in patients with cystic fibrosis (CF) and exocrine pancreatic insufficiency (PI). Aim. To evaluate efficacy and safety of a new formulation of pancrelipase (Ultrase MT20) in patients with CF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Konstan, Michael W., Liou, Theodore G., Strausbaugh, Steven D., Ahrens, Richard, Kanga, Jamshed F., Graff, Gavin R., Moffett, Kathryn, Millard, Susan L., Nasr, Samya Z., Siméon, Édith, Spénard, Jean, Grondin, Josée
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004382/
https://www.ncbi.nlm.nih.gov/pubmed/21197074
http://dx.doi.org/10.1155/2010/898193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004382/
https://www.ncbi.nlm.nih.gov/pubmed/21197074
http://dx.doi.org/10.1155/2010/898193

Ejemplares similares